Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome

被引:194
作者
Hobbs, Jenny B.
Peterson, Derick R.
Moss, Arthur J.
McNitt, Scott
Zareba, Wojciech
Goldenberg, Ilan
Qi, Ming
Robinson, Jennifer L.
Sauer, Andrew J.
Ackerman, Michael J.
Benhorin, Jesaia
Kaufman, Elizabeth S.
Locati, Emanuela H.
Napolitano, Carlo
Priori, Silvia G.
Towbin, Jeffrey A.
Vincent, G. Michael
Zhang, Li
机构
[1] Univ Rochester, Med Ctr, HeartRes Followup Program, Dept Med,Cardiol Unit, Rochester, NY 14642 USA
[2] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA
[3] Univ Rochester, Med Ctr, Dept Pathol, Rochester, NY 14642 USA
[4] Mayo Clin Coll Med, Dept Med, Rochester, MN USA
[5] Mayo Clin Coll Med, Dept Pediat, Rochester, MN USA
[6] Mayo Clin Coll Med, Dept Mol Pharmacol, Rochester, MN USA
[7] Bikur Cholim Hosp, Dept Cardiol, Jerusalem, Israel
[8] Case Western Reserve Univ, Heart & Vasc Res Ctr, Cleveland, OH 44106 USA
[9] Osped Niguarda Ca Granda, Cardiovasc Dept De Gasperis, Milan, Italy
[10] Univ Pavia, Fdn S Maugeri, I-27100 Pavia, Italy
[11] Baylor Coll Med, Dept Pediat Cardiol, Houston, TX 77030 USA
[12] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2006年 / 296卷 / 10期
关键词
D O I
10.1001/jama.296.10.1249
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Analysis of predictors of cardiac events in hereditary long-QT syndrome (LQTS) has primarily considered syncope as the predominant end point. Risk factors specific for aborted cardiac arrest and sudden cardiac death have not been investigated. Objective To identify risk factors associated with aborted cardiac arrest and sudden cardiac death during adolescence in patients with clinically suspected LQTS. Design, Setting, and Participants The study involved 2772 participants from the International Long QT Syndrome Registry who were alive at age 10 years and were followed up during adolescence until age 20 years. The registry enrollment began in 1979 at 5 cardiology centers in the United States and Europe. Main Outcome Measures Aborted cardiac arrest or LQTS-related sudden cardiac death; follow-up ended on February 15, 2005. Results There were 81 patients who experienced aborted cardiac arrest and 45 who had sudden cardiac death; 9 of the 81 patients who had an aborted cardiac arrest event experienced subsequent sudden cardiac death. Significant independent predictors of aborted cardiac arrest or sudden cardiac death during adolescence included recent syncope, QTc interval, and sex. Compared with those with no syncopal events in the last 10 years, patients with 1 or 2 or more episodes of syncope 2 to 10 years ago (but none in the last 2 years) had an adjusted hazard ratio (HR) of 2.7; (95% confidence interval [CI], 1.3-5.7; P < .01) and an adjusted HR of 5.8 (95% CI, 3.6-9.4; P < .001), respectively, for life-threatening events; those with 1 syncopal episodes in the last 2 years had an adjusted HR of 11.7 (95% CI, 7.0-19.5; P < .001) and those with 2 or more syncopal episodes in the last 2 years had an adjusted HR of 18.1 (95% CI, 10.4-31.2; P < .001). Irrespective of events occurring more than 2 years ago, QTc of 530 ms or longer was associated with increased risk (adjusted HR, 2.3; 95% CI, 1.6-3.3; P < .001) compared with those having a shorter QTc. Males between the ages of 10 and 12 years had higher risk than females (HR, 4.0; 95% CI, 1.8-9.2; P = .001), but there was no significant risk difference between males and females between the ages of 13 and 20 years. Among individuals with syncope in the past 2 years, beta-blocker therapy was associated with a 64% reduced risk (HR, 0.36; 95% CI, 0.18-0.72; P < .01). Conclusions In LQTS, the timing and frequency of syncope, QTc prolongation, and sex were predictive of risk for aborted cardiac arrest and sudden cardiac death during adolescence. Among patients with recent syncope, beta-blocker treatment was associated with reduced risk.
引用
收藏
页码:1249 / 1254
页数:6
相关论文
共 23 条
[1]  
Benhorin J, 2002, ANN NONINVAS ELECTRO, V7, P40
[2]   Sex differences on the electrocardiographic pattern of cardiac repolarization: Possible role of testosterone [J].
Bidoggia, H ;
Maciel, JP ;
Capalozza, N ;
Mosca, S ;
Blaksley, EJ ;
Valverde, E ;
Bertran, G ;
Arini, P ;
Biagetti, MO ;
Quinteiro, RA .
AMERICAN HEART JOURNAL, 2000, 140 (04) :678-683
[3]   HORMONAL-REGULATION OF K+-CHANNEL MESSENGER-RNA IN RAT MYOMETRIUM DURING ESTRUS CYCLE AND IN PREGNANCY [J].
BOYLE, MB ;
MACLUSKY, NJ ;
NAFTOLIN, F ;
KACZMAREK, LK .
NATURE, 1987, 330 (6146) :373-375
[4]   Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart [J].
Drici, MD ;
Burklow, TR ;
Haridasse, V ;
Glazer, RI ;
Woosley, RL .
CIRCULATION, 1996, 94 (06) :1471-1474
[5]   Clinical implications for affected parents and siblings of probands with long-QT syndrome [J].
Kimbrough, J ;
Moss, AJ ;
Zareba, W ;
Robinson, JL ;
Hall, J ;
Benhorin, J ;
Locati, EH ;
Medina, A ;
Napolitano, C ;
Priori, S ;
Schwartz, PJ ;
Timothy, K ;
Towbin, JA ;
Vincent, GM ;
Zhang, L .
CIRCULATION, 2001, 104 (05) :557-562
[6]   Age-gender influence on the rate-corrected QT interval and the QT-heart rate relation in families with genotypically characterized long QT syndrome [J].
Lehmann, MH ;
Timothy, KW ;
Frankovich, D ;
Fromm, BS ;
Keating, M ;
Locati, EH ;
Taggart, RT ;
Towbin, JA ;
Moss, AJ ;
Schwartz, PJ ;
Vincent, GM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (01) :93-99
[7]  
Liu XK, 1998, J PHARMACOL EXP THER, V285, P672
[8]   Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome - Findings from the international LQTS registry [J].
Locati, EH ;
Zareba, W ;
Moss, AJ ;
Schwartz, PJ ;
Vincent, GM ;
Lehmann, MH ;
Towbin, JA ;
Priori, SG ;
Napolitano, C ;
Robinson, JL ;
Andrews, M ;
Timothy, K ;
Hall, WJ .
CIRCULATION, 1998, 97 (22) :2237-2244
[9]   ELECTROCARDIOGRAPHIC QUANTITATION OF VENTRICULAR REPOLARIZATION [J].
MERRI, M ;
BENHORIN, J ;
ALBERTI, M ;
LOCATI, E ;
MOSS, AJ .
CIRCULATION, 1989, 80 (05) :1301-1308
[10]   The QT interval and torsade de pointes [J].
Moss, AJ .
DRUG SAFETY, 1999, 21 (Suppl 1) :5-10